Nexalin Technology, Inc. Equity Method Investment, Ownership Percentage
Nexalin Technology, Inc. (NXL) had Equity Method Investment, Ownership Percentage of 52.00% as of 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2025-03-14
- 2024-12-31: Equity Method Investment, Ownership Percentage 52.00%.
- 2023-12-31: Equity Method Investment, Ownership Percentage 48.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2024-12-31 | 52.00% 10-K · filed 2025-03-14 |
| 2023-12-31 | 48.00% 10-K · filed 2025-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |